The author describes a methodology for developing a per product qualitative and semi-qualitative business case for applying QbD to a biopharmaceutical product.
Beth H. Junker
Advertisement
Beth H. Junker is the senior director of fermentation and development operations at Merck Research Laboratories
Articles by Beth H. Junker
How to optimize facility utilization and improve plant performance.
Translate the concepts in to practical applications and reduce waste.
Applying Operational Excellence Concepts to Biopharmaceutical Processing. Supplemental Tables. (PDF)
Supplemental tables for the above-mentioned article, providing additional information about the application of operational excellence methods.
Advertisement
Latest Updated Articles
Building a Business Case for Biopharmaceutical QbD Implementation (Peer Reviewed)Published: August 1st 2012 | Updated:
Application of Overall Equipment Effectiveness to Biopharmaceutical ManufacturingPublished: May 1st 2009 | Updated:
Applying Operational Excellence Concepts to Biopharmaceutical ProcessingPublished: November 1st 2008 | Updated:
- Applying Operational Excellence Concepts to Biopharmaceutical Processing. Supplemental Tables. (PDF)
Published: November 1st 2008 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
3
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
4
